secwatch.observer — SEC 8-K summary
======================================

Issuer:     GYRE THERAPEUTICS, INC. (GYRE)
CIK:        0001124105
Form:       8-K
Filed at:   2021-07-15T23:59:59+00:00
Accession:  0001193125-21-216469
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Catalyst Biosciences promotes Grant Blouse to CSO; CMO Howard Levy to retire Aug 15
--------------------------------------------------------------------------------

- Grant Blouse promoted to Chief Scientific Officer from SVP Translational Research; base salary $414,000 annually.
- Blouse eligible for annual performance-based bonus up to 40% of base salary.
- CMO Howard Levy to retire effective Aug 15, 2021; will join Clinical Advisory Board for hemophilia programs.
- Levy's retirement not due to any disagreement with the company or its management.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1124105/000119312521216469/0001193125-21-216469-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1124105/000119312521216469/d125524d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-21-216469

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer